Millennium Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.22M Hold
50,000
– – ﹤0.01% 4326
2026
Q2
$1.72M Buy
+50,000
New +$1.51M ﹤0.01% 3937
2026
Q1
– Sell
-150,000
Closed -$4.16M – 5714
2025
Q4
$4.16M Buy
+150,000
New +$3.83M ﹤0.01% 3210

Other funds holding BEAM

Millennium Management's BEAM Position: Q3 2026 in Review

Millennium Management reduced its Beam Therapeutics (BEAM) stake by 34% in Q3 2026, selling an estimated $321K and leaving 22,725 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #4954.

Millennium Management first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $33.1M in Q1 2022. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Millennium Management held 22,725 shares of Beam Therapeutics worth $556K as of Q3 2026.
  • Millennium Management sold 11,535 Beam Therapeutics shares in Q3 2026, an estimated $321K.
  • Beam Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4954 holding.
  • Millennium Management first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Millennium Management's Beam Therapeutics position peaked at $33.1M in Q1 2022.
  • 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.